AUSTRALIA'S only locally manufactured influenza vaccine is now available for the private market, as well as being listed on the National Immunisation Program for the 2017 flu season (PD 07 Mar).
Seqirus manufactures Afluria Quad (inactivated quadrivalent seasonal influenza vaccine - split virion) in its Melbourne plant, with the company aiming to bring flu vaccine early to Australia each year.
Afluria Quad will replace the company's trivalent vaccine (TIV), Fluvax for this year's season, while the name change to Afluria brings consistency across Seqirus' global influenza brand portfolio.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Mar 17
